Google DeepMind AlphaFold 3 Now Predicts RNA-Protein Interactions With Clinical Research Applications

## AlphaFold Expands Beyond Proteins Google DeepMind released a significant update to AlphaFold 3 this week, extending the model's structural prediction capabilities to RNA-protein interactions with accuracy that rivals experimental methods. The update is immediately available through the AlphaFold Server for non-commercial research use, with API access for pharmaceutical and biotech companies through Google Cloud. ## Why RNA-Protein Interactions Matter Proteins and RNA interact constantly in cellular machinery — ribosomes are RNA-protein complexes, many gene regulatory systems involve RNA binding proteins, and a growing class of therapeutics (including mRNA vaccines and RNA interference drugs) depend on understanding these interactions at the molecular level. Until now, experimental determination of RNA-protein complex structures required months of crystallography or cryo-EM work. AlphaFold 3's updated model predicts these structures in seconds. ## Accuracy Benchmarks On the RNA-Puzzles benchmark, AlphaFold 3's updated model achieves median TM-score of 0.87 for RNA-protein complexes, compared to 0.63 for the best prior computational methods. For free-standing RNA structures (not in complex with protein), performance is slightly lower at 0.81, reflecting the greater conformational flexibility of RNA compared to protein. ## Research Applications Early adopters include groups at Harvard Medical School using the tool to understand how mutation-disrupted RNA binding causes amyotrophic lateral sclerosis (ALS), and pharma companies developing RNA-targeting small molecule drugs. The commercial applications in RNA therapeutics alone represent a multi-billion dollar research acceleration opportunity. ## Open Science Commitment DeepMind continues to provide AlphaFold Server access free for academic research, a policy that has made it the most widely used structural biology tool globally.